Explore the categories so you can find more about your search.

Categorie > Cholesterol

Risk For Coronary Artery Disease And New Genetic Variants Associated With Lipid Levels

Categorie : Cholesterol
Environmental and genetic factors influence a person's blood fat, or lipid levels, important risk factors for coronary artery disease (CAD). While there is some understanding of the environmental contribution, the role of genetics has been less defined. Now, in an international collaboration support ...

read more Environmental and genetic factors influence a person's blood fat, or lipid levels, important risk factors for coronary artery disease (CAD). While there is some understanding of the environmental contribution, the role of genetics has been less defined. Now, in an international collaboration support read more Tue Jan 2008 Tue Jan 2008

Researchers Report Breakthrough In Lowering Cholesterol, Fatty Acids

Categorie : Cholesterol
Researchers at the University of Alberta, in Edmonton, Canada, have found a way to reduce the amount of bad cholesterol and fatty acids that end up in the blood from food the body metabolizes, a key discovery that could lead to new drugs to treat and reverse the effects of Type 2 diabetes and heart ...

read more Researchers at the University of Alberta, in Edmonton, Canada, have found a way to reduce the amount of bad cholesterol and fatty acids that end up in the blood from food the body metabolizes, a key discovery that could lead to new drugs to treat and reverse the effects of Type 2 diabetes and heart read more Tue Jan 2008 Tue Jan 2008

Breakthrough In Lowering Bad Cholesterol, Fatty Acid Levels Could Lead To New Treatments For Heart Disease, Diabetes

Categorie : Cholesterol
There is "heartening" news out of the University of Alberta for those who may have overindulged during the recent holidays.U of A medical researchers have found a way to reduce the amount of bad cholesterol and fatty acids that end up in the blood from food the body metabolizes, a key discovery that ...

read more There is read more Tue Jan 2008 Tue Jan 2008

Study Results Provide Surprise Benefits Of Cholesterol

Categorie : Cholesterol
If you're worried about high cholesterol levels and keeping heart-healthy as you get older, don't push aside bacon and eggs just yet. A new study says they might actually provide a benefit.Researchers at Texas A&M University have discovered that lower cholesterol levels can actually reduce muscle ga ...

read more If you're worried about high cholesterol levels and keeping heart-healthy as you get older, don't push aside bacon and eggs just yet. A new study says they might actually provide a benefit.Researchers at Texas A&M University have discovered that lower cholesterol levels can actually reduce muscle ga read more Tue Jan 2008 Tue Jan 2008

Science Strongly Reaffirms Oatmeal's Health Claims

Categorie : Cholesterol
A new scientific review of the most current research shows the link between eating oatmeal and cholesterol reduction to be stronger than when the FDA initially approved the health claim's appearance on food labels in 1997.Dr. James W. ...

read more A new scientific review of the most current research shows the link between eating oatmeal and cholesterol reduction to be stronger than when the FDA initially approved the health claim's appearance on food labels in 1997.Dr. James W. read more Tue Jan 2008 Tue Jan 2008

FDA Panel Considers Allowing Over-the-Counter Sales Of Low-Dose Cholesterol Medication

Categorie : Cholesterol
An FDA advisory committee on Thursday will meet to consider an application from Merck to market the 20-milligram dose of the anticholesterol medication Mevacor over the counter, the Newark Star-Ledger reports (Todd/Cohen, Newark Star-Ledger, 12/12). [click link for full article] ...

read more An FDA advisory committee on Thursday will meet to consider an application from Merck to market the 20-milligram dose of the anticholesterol medication Mevacor over the counter, the Newark Star-Ledger reports (Todd/Cohen, Newark Star-Ledger, 12/12). [click link for full article] read more Mon Dec 2007 Mon Dec 2007

Cholesterol Lowering Drugs And The Risk Of Hemorrhagic Stroke

Categorie : Cholesterol
People taking cholesterol lowering drugs such as atorvastatin after a stroke may be at an increased risk of hemorrhagic stroke, or bleeding in the brain, a risk not found in patients taking statins who have never had a stroke. But researchers caution the risk must be balanced against the much larger ...

read more People taking cholesterol lowering drugs such as atorvastatin after a stroke may be at an increased risk of hemorrhagic stroke, or bleeding in the brain, a risk not found in patients taking statins who have never had a stroke. But researchers caution the risk must be balanced against the much larger read more Mon Dec 2007 Mon Dec 2007

High Triglycerides, Other Cholesterol Raise Risk Of Stroke

Categorie : Cholesterol
People with high triglycerides and another type of cholesterol tested but not usually evaluated as part of a person's risk assessment have an increased risk of a certain type of stroke, according to research published in the December 26, 2007, online issue of Neurology®, the medical journal of the A ...

read more People with high triglycerides and another type of cholesterol tested but not usually evaluated as part of a person's risk assessment have an increased risk of a certain type of stroke, according to research published in the December 26, 2007, online issue of Neurology®, the medical journal of the A read more Mon Dec 2007 Mon Dec 2007

Hearing Fine Tuned By Cholesterol

Categorie : Cholesterol
Levels of cholesterol in the membranes of hair cells in the inner ear can affect your hearing, said a consortium of researchers from Baylor College of Medicine, Rice University and Purdue University in a report in the print edition of The Journal of Biological Chemistry.Dr. William Brownell, profess ...

read more Levels of cholesterol in the membranes of hair cells in the inner ear can affect your hearing, said a consortium of researchers from Baylor College of Medicine, Rice University and Purdue University in a report in the print edition of The Journal of Biological Chemistry.Dr. William Brownell, profess read more Mon Dec 2007 Mon Dec 2007

New Cholesterol Drug Set To Decrease Heart Attack Risk

Categorie : Cholesterol
The first clinical trial of a new kind of drug to cut the risk of cardiovascular disease has been found safe and effective at dropping levels of "bad" low density lipoprotein (LDL) cholesterol by as much as 40 percent. High LDL levels increase the risk for heart attack and stroke.The drug mimics the ...

read more The first clinical trial of a new kind of drug to cut the risk of cardiovascular disease has been found safe and effective at dropping levels of read more Mon Dec 2007 Mon Dec 2007

FDA Advisory Panel Recommends Against Approval Of Merck's NDA For Non Prescription MEVACOR® (lovastatin) 20 Mg

Categorie : Cholesterol
Merck & Co., Inc. announced that the U.S. Food and Drug Administration's (FDA) joint panel of the Nonprescription Drugs Advisory Committee (NDAC) and the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) voted against recommending approval at this time of the over-the-counter (OTC) use o ...

read more Merck & Co., Inc. announced that the U.S. Food and Drug Administration's (FDA) joint panel of the Nonprescription Drugs Advisory Committee (NDAC) and the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) voted against recommending approval at this time of the over-the-counter (OTC) use o read more Mon Dec 2007 Mon Dec 2007

Average Cholesterol Level For U.S. Adults Reaches Recommended Range For First Time In Almost 50 Years

Categorie : Cholesterol
The average cholesterol level for U.S. adults last year decreased to 199 and reached the recommended range for the first time in almost 50 years, according to a report released by CDC on Wednesday, the AP/Long Island Newsday reports. The report uses data collected by CDC every two years. [click link ...

read more The average cholesterol level for U.S. adults last year decreased to 199 and reached the recommended range for the first time in almost 50 years, according to a report released by CDC on Wednesday, the AP/Long Island Newsday reports. The report uses data collected by CDC every two years. [click link read more Mon Dec 2007 Mon Dec 2007

Clinical Trial Of New Drug Shows Reduction In Abdominal Fat Accumulation And Improvement In Lipids In HIV-Infected Patients

Categorie : Cholesterol
Treatment with an investigational drug that induces the release of growth hormone significantly improved the symptoms of HIV lipodystrophy, a condition involving the redistribution of fat and other metabolic changes in patients receiving combination drug therapy for HIV infection. [click link for fu ...

read more Treatment with an investigational drug that induces the release of growth hormone significantly improved the symptoms of HIV lipodystrophy, a condition involving the redistribution of fat and other metabolic changes in patients receiving combination drug therapy for HIV infection. [click link for fu read more Sun Dec 2007 Sun Dec 2007

Skin Cholesterol Linked To Cardiovascular Disease Risk In Asymptomatic Individuals

Categorie : Cholesterol
PreMD Inc. (TSX:PMD;AMEX:PME) announced that the company's novel non-invasive skin cholesterol test has demonstrated the ability to detect risk of cardiovascular disease in asymptomatic subjects, according to new data being presented this morning at the Annual Scientific Sessions of the American Hea ...

read more PreMD Inc. (TSX:PMD;AMEX:PME) announced that the company's novel non-invasive skin cholesterol test has demonstrated the ability to detect risk of cardiovascular disease in asymptomatic subjects, according to new data being presented this morning at the Annual Scientific Sessions of the American Hea read more Sun Dec 2007 Sun Dec 2007

Synvista Collaboration Demonstrates In Preclinical Studies The Mechanism For Defective Cholesterol Transport In Patients With Diabetes

Categorie : Cholesterol
Synvista Therapeutics, Inc. (Amex: SYI) announced results of a series of preclinical studies designed to explain the mechanism underlying dysfunctional high density lipoprotein (HDL), that creates a defect in reverse cholesterol transport in patients with Diabetes Mellitus (DM). [click link for full ...

read more Synvista Therapeutics, Inc. (Amex: SYI) announced results of a series of preclinical studies designed to explain the mechanism underlying dysfunctional high density lipoprotein (HDL), that creates a defect in reverse cholesterol transport in patients with Diabetes Mellitus (DM). [click link for full read more Sun Dec 2007 Sun Dec 2007

Abbott's Investigational SIMCOR® Offers Comparable LDL Lowering To Simvastatin And Significantly Raises HDL And Lowers Triglycerides In Phase III

Categorie : Cholesterol
New data released showed that Abbott's SIMCOR®, an investigational, fixed-dose combination of Abbott's proprietary extended-release niacin, Niaspan®, and simvastatin met its primary endpoint of lowering plaque-promoting non-HDL cholesterol (total cholesterol minus HDL), while demonstrating improveme ...

read more New data released showed that Abbott's SIMCOR®, an investigational, fixed-dose combination of Abbott's proprietary extended-release niacin, Niaspan®, and simvastatin met its primary endpoint of lowering plaque-promoting non-HDL cholesterol (total cholesterol minus HDL), while demonstrating improveme read more Sun Dec 2007 Sun Dec 2007

Study Of Soy Labs' Lunasin Demonstrates Its Cholesterol Lowering Properties

Categorie : Cholesterol
A new in vitro study of Lunasin has demonstrated its potential to reduce cholesterol levels by inhibiting the expression of a gene known to be responsible for internal cholesterol production and increasing expression of a gene which reduces plasma LDL cholesterol. A recently discovered bioactive soy ...

read more A new in vitro study of Lunasin has demonstrated its potential to reduce cholesterol levels by inhibiting the expression of a gene known to be responsible for internal cholesterol production and increasing expression of a gene which reduces plasma LDL cholesterol. A recently discovered bioactive soy read more Sun Dec 2007 Sun Dec 2007

More Young Adults Take Anticholesterol, Hypertension Medications, Report Finds

Categorie : Cholesterol
The percentage of young adults who take anticholesterol and hypertension medications has increased significantly in recent years, according to a report released on Tuesday by pharmacy benefit manager Medco Health Solutions, the AP/Washington Times reports. [click link for full article] ...

read more The percentage of young adults who take anticholesterol and hypertension medications has increased significantly in recent years, according to a report released on Tuesday by pharmacy benefit manager Medco Health Solutions, the AP/Washington Times reports. [click link for full article] read more Sun Dec 2007 Sun Dec 2007

Anthera Announces Positive Phase II Clinical Results From A-002 Cardiovascular Disease Trial

Categorie : Cholesterol
Anthera Pharmaceuticals, Inc., a privately-held biopharmaceutical company, reported results of a Phase II clinical trial of its first compound, A-002, for the treatment of cardiovascular disease. [click link for full article] ...

read more Anthera Pharmaceuticals, Inc., a privately-held biopharmaceutical company, reported results of a Phase II clinical trial of its first compound, A-002, for the treatment of cardiovascular disease. [click link for full article] read more Sun Dec 2007 Sun Dec 2007

NICE Publishes Guidance On EZETROL (Ezetimibe) For The Treatment Of Adults With Primary Hypercholesterolemia, UK

Categorie : Cholesterol
The National Institute for Health and Clinical Excellence (NICE) has published Guidance recommending that adding EZETROL(R) (ezetimibe) to initial statin therapy is a treatment option for patients whose cholesterol is not appropriately controlled on the initial statin, after appropriate dose titrat ...

read more The National Institute for Health and Clinical Excellence (NICE) has published Guidance recommending that adding EZETROL(R) (ezetimibe) to initial statin therapy is a treatment option for patients whose cholesterol is not appropriately controlled on the initial statin, after appropriate dose titrat read more Sun Dec 2007 Sun Dec 2007

<<< previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 next >>>



     


Custom Search